BACKGROUND: Skeletal dysplasia comprises a heterogeneous and collectively common group of inherited disorders of development, growth, and maintenance of the human skeleton. There is potential for increased perinatal morbidity and mortality in pregnant women who themselves have skeletal dysplasia, and for affected fetuses where skeletal dysplasia is suspected in utero. OBJECTIVE: We sought to establish guidelines for perinatal health care professionals who should be aware of these risks, to optimize maternal and child health pregnancy outcomes through best prenatal and delivery management practices. STUDY DESIGN: A panel of 13 multidisciplinary international experts participated in a Delphi process, which comprised consideration of thorough literature review and a list of 54 possible care recommendations subject to 2 rounds of anonymous voting and a face-to-face meeting. Those recommendations with >80% agreement were considered as consensual. RESULTS: During the first round, consensus was reached to support 30 out of the 54 statements. After the panel discussion, the group reached consensus on 40 statements. These statements include guidelines for the evaluation and treatment of pregnant women with skeletal dysplasia and for the unborn child with or suspected to have skeletal dysplasia. CONCLUSION: Consensus-based best practice guidelines are provided as a minimum of standard care to minimize associated health risks, and improve clinical outcomes for patients with skeletal dysplasia.
Introduction
Skeletal dysplasia represents a heterogeneous and collectively common group of inherited disorders of development, growth, and maintenance of the human skeleton.
1,2 Many of these conditions have their onset in the prenatal period and might be suspected prior to birth, following routine ultrasonography. Depending on the inheritance of the individual condition, adults with skeletal dysplasia may pass on the trait to their offspring, requiring special precautions. In addition, pregnant women with skeletal dysplasia may face physical restraints because of their own condition where there is potential for increased perinatal morbidity and mortality. The increased risk of pregnancy in these situations is related to multiple factors such as cardiopulmonary and musculoskeletal considerations in pregnant women with skeletal dysplasia, and potential cervical spine instability in suspected fetal skeletal dysplasia. These issues, combined with the individual rarity of these conditions, make it paramount that relevant pregnancies are uniformly assessed and managed in facilities that are aware of these potential complications, and have the skill and resources to anticipate and manage them effectively. These guidelines aim to make relevant perinatal health care professionals aware of these risks, and assist them in optimizing maternal and child health pregnancy outcomes through best prenatal and delivery management practices.
Materials and Methods
This study was exempt of institutional review board approval because it is based on a structured process of group consensus. A RANDeUniversity of California Los Angeles modified Delphi method was used to create consensusbased guidelines for the perioperative practices in patients with skeletal dysplasia. Briefly, this methodology consists of a systematic literature review, creation of a list of statements or indications, multiple rounds of vetting those statements, and a face-to-face meeting where these parameters are rated anonymously by a group of experts. 3e5 This methodology has been widely used in medical research to determine appropriate treatment and best practice guidelines. 6e8 This group has employed this methodology previously with the aim of improving standards of management, and stimulating further research to optimize health outcomes for individuals with skeletal dysplasia. 9, 10 The lead author (R.S.) created a list of statements based on a systematic literature review. The first electronic survey consisted of 22 statements and was distributed, along with the referenced literature search, to a panel of international experts in October 2016 (round 1). Respondents rated the statements using a 5-point Likert scale (strongly agree, agree, neutral, disagree, and strongly disagree). A month later, at a face-to-face meeting, the results of the survey and the literature review were presented. During the meeting, the panel decided to add 32 new statements to cover issues regarding maternal care that were omitted during the first round. These statements were rated for the first time in the first part of the meeting. In the second part of the meeting, participants focused the discussion on the areas of disagreement, and were given the opportunity to modify the statements if required. A series of modifications were suggested by the panel, and participants had the opportunity to rate the 54 statements anonymously for a second time using an electronic survey (round 2).
Consensus of 80% is considered the standard for most Delphi processes, and in this case, that percentage was agreed a priori. Statements with !80% of agreement between 2 categories (strongly agree and agree; or strongly disagree or disagree) were interpreted as "appropriate" or "inappropriate" and included in the guidelines. The panel consisted of 13 international experts on skeletal dysplasia. Specialists were selected based on their clinical expertise and track record of relevant research. A total of 6 pediatric orthopedic surgeons, 4 geneticists, 2 obstetricians and gynecologists, and 1 pediatric radiologist participated in this effort.
Results
The mean years in practice for the panel of experts was 22 (range 10e45 years). The panel have an average of 17 years (range 10e41 years) treating patients with skeletal dysplasia. During round 1, 30 out of 54 statements reached consensus of !80% (Table 1) . The statements that did not reach consensus were related to prenatal diagnosis imaging, time of diagnosis, and predictors of suspected skeletal dysplasia ( Table 2 ).
In the face-to-face meeting, the list was modified into 42 statements. This list was rated in round 2, where 40 statements reached !80% consensus (Table 3) and only 2 statements did not (Table 4) .
After review of the results, all participants agreed to support its publication.
Comment
Pregnancy and delivery in women with skeletal dysplasia 1) Preconception genetic counseling is recommended for individuals and/or partners who have skeletal dysplasia or are at increased chance of having a fetus with skeletal dysplasia.
Most types of skeletal dysplasia are the result of a genetic mutation, with a minority being associated with teratogenic environmental exposure, multisystem syndromes, or chromosomal anomalies. Nosological classification of the >450 different types illustrates the varied underlying molecular basis. 2 This observation therefore necessitates genetic counseling, ideally preconception, to discuss the offspring risk of skeletal dysplasia.
This counseling should take into consideration the following: family history to ascertain known Mendelian inheritance, pregnancy history to ensure there were no environmental factors causing skeletal dysplasia, and accurate diagnostic consideration of the skeletal dysplasia condition. While a number of conditions follow a clear inheritance pattern, many are the consequence of a de novo mutation and thereafter have the potential for transmission to the next generation if they are a new dominant event. The objective of preconception Expert Reviews ajog.org genetic counseling is to help individuals understand the chance of passing on a skeletal dysplasia condition, its possible vprognosis, and to plan possible management.
2) Preconception medical evaluation is recommended to consider factors that may impact safety of pregnancy, mode of delivery, and anesthetic management (eg, airway, cardiopulmonary status, and neuraxial and musculoskeletal structure and function).
Preconception medical evaluation is recommended for all women with skeletal dysplasia who are considering a pregnancy. This should be undertaken before they conceive, since the overall objective is to consider factors that may impact safety of pregnancy, mode of delivery, and anesthetic management. The latter might be impacted by anatomical considerations over their airway, their cardiopulmonary status, and neuraxial and musculoskeletal structure and function. Investigations might include radiographic imaging of the pelvic outlet, which is therefore most appropriately conducted in advance of a pregnancy. General health status, which would include assessment for hypertension, significantly raised body mass index (BMI), glucose intolerance, and respiratory compromise should also be undertaken. 11 Each type of skeletal dysplasia, dependent upon the specific nature of the individual condition, is associated with different musculoskeletal characteristics, 12 for example early degenerative diseases of the large joints and the spine, kyphoscoliosis, spinal stenosis, and odontoid hypoplasia. Musculoskeletal assessment by an experienced obstetric physician of such conditionspecific factors is required prior to conception and should be actively reviewed during the pregnancy, as exacerbation frequently occurs. In addition, the requirement for active management of associated pain that may develop should also be anticipated. 13 Biomechanical and anatomical factors associated with skeletal dysplasia on an individual basis will determine the most appropriate mode of delivery and should be anticipated early in delivery planning.
3) Standard recommendations for weight gain during pregnancy are not applicable to women with skeletal dysplasia.
For several decades, guidelines for appropriate weight gain during pregnancy, or gestational weight gain (GWG), have been based on the recommendations of the Institute of Medicine (IOM), most recently updated in 2009. 14 The American Congress of Obstetricians and Gynecologists (ACOG) adopted these guidelines. 15 The goals of appropriate GWG are to optimize maternal and child health outcomes, including appropriately sized babies, increasing the likelihood of vaginal birth, avoiding postpartum weight retention, and encouraging lactation performance, among other goals. Recommended weight gain is stratified by prepregnancy World Health Organization BMI standard ranges of underweight (BMI <18.5 kg/m . As BMI increases, recommended GWG decreases, with a recommended weight gain of 5e9 kg (11e20 lb) for women in the obese range of prepregnancy BMI. The IOM report includes 1 paragraph to address women of short stature (defined as <157 cm, w5'2"); it references the 1990 guidelines, which recommended they "gain at the lower end of the range for their prepregnant BMI." However, the paragraph in the 2009 guidelines goes on to state, "No information was available with which to evaluate whether a modification of guidelines might be necessary for very short (<150 cm, w4'11") women." Thus, women with dwarfism are essentially excluded from the IOM guidelines. Adding to the difficulty in assessing appropriate GWG for women with dwarfism is the reality that BMI does not take into consideration body proportions, 16 thus guidelines based entirely on BMI are problematic. Despite the need, body measurements to accurately assess nutritional status for the various forms of skeletal dysplasia have not yet been established. Nevertheless, obstetricians are left to make recommendations for appropriate GWG to women with skeletal dysplasia. In the absence of research and/or published guidelines, this expert panel agrees that the standard recommendations are not applicable. A reasonable approximation is to recommend GWG in the lowest range, a total of 11e20 lb (5e9 kg) over the course of pregnancy. This is sufficient for adequate nutrition for the growing fetus, will minimize the impact on the maternal skeletal and respiratory systems, and avoid excess postpartum weight retention.
4)
Women with skeletal dysplasia are not at a higher risk for preterm labor (24e37 weeks of gestation), but may need delivery prior to term.
The incidence of preterm birth (<37 completed weeks of gestation) in the United States in 2014 was 9.57%. 17 These births are the result of many factors, including preterm labor and medical and obstetric factors necessitating preterm delivery. The medical literature regarding pregnancy outcome in women with dwarfism is limited almost exclusively to case reports, which does not permit an overall estimate of the timing of delivery. In a survey of 61 women with dwarfism who had 99 pregnancies resulting in live births, 86 were reportedly term. 18 The 13% preterm birth rate is only slightly higher than the general population. This has also been the experience of obstetrical medical geneticists who have cared for many women with dwarfism.
Women with short trunk forms of dwarfism, such as spondyloepiphyseal dysplasia, osteogenesis imperfecta, and mucopolysaccharidoses, may experience significant respiratory compromise as the uterus enlarges and encroaches on normal diaphragm excursion. If this complication cannot be managed adequately with position and/or respiratory support, such as continuous positive airway pressure, early delivery may become necessary. Careful consideration must be given to balancing the risks of pregnancy prolongation on ajog.org Expert Reviews maternal status and the risks of prematurity for the infant.
5)
Careful attention to fluid management in women with skeletal dysplasia is required to avoid fluid overload in the peripartum period.
Despite the reality that women who deliver in the hospital in the United States routinely receive continuous intravenous fluids, there is very little written regarding the volume of fluid they should receive. For example, the Guidelines for Perinatal Care, a publication written in collaboration between the American Academy of Pediatrics and ACOG, makes no reference to fluid management in labor, 19 nor do the major obstetrics text books. A few articles describe maternal and neonatal hyponatremia due to water intoxication, and recommend "attention to the risk of fluid overload during labor." 20, 21 Contributing factors to fluid overload risk are the recommendation for fluid preloading to avoid maternal hypotension with epidural placement 22 and the antidiuretic effect of oxytocin, both endogenous and infused.
In women with skeletal dysplasia, the volume of distribution of fluids is proportionate to their stature. This should be considered when dosing infusions. Rather than following usual practice, such as infusion of 1 L of fluids prior to epidural placement or general anesthesia, and/or bolusing with up to 500 mL for maternal hypotension or fetal heart rate abnormalities, consideration should be given to the patient's size and adjustments in infusion volume and rate be made accordingly.
6)
In women with skeletal dysplasia, the standard management of preterm labor may need to be modified.
Preterm birth is defined as delivery <37 completed weeks of gestation. In 2015, the preterm birth rate (<37 weeks) in the United States was 9.63% and the early preterm birth rate (<34 weeks) was 2.76%. 23 Approximately half of preterm births are the result of preterm labor. 24 Typically, rigorous efforts are undertaken to treat preterm labor <32e34 completed weeks in an effort to avoid preterm birth and the associated morbidity and mortality for the neonate. In its 2016 Practice Bulletin on the management of preterm labor, the ACOG recommends, ". only women with fetuses that would benefit from a 48ehour delay in delivery should receive tocolytic treatment." 25 This is to allow administration of antenatal corticosteroids, which improve neonatal outcomes, including respiratory distress syndrome, intracranial hemorrhage, necrotizing enterocolitis, and death. 26 Standard management of preterm labor includes: diagnosisetypically made due to the presence of regular contractions accompanied by cervical change, hydration with intravenous fluids in an attempt to stop contractions, then use of !1 tocolytic agents. The most commonly used tocolytics in the United States are nifedipine (calcium channel blocker), indomethacin (nonsteroidal antiinflammatory drug), terbutaline (beta-adrenergic receptor against), and magnesium sulfate. 25 Many obstetricians have their preferred regimen, as the literature does not strongly favor one over the others. The goal is to prolong pregnancy for 48 hours to allow corticosteroid administration.
The diagnosis of preterm labor in women with dwarfism may be complicated by the small pelvis, which can make a cervical exam difficult. The usually simple act of assessing cervical dilation, a vital part of the diagnosis, may be difficult to impossible, depending on the location of the cervix and the shape of the pelvis. Another factor is that the fetal head often does not descend into the pelvis because of the narrow inlet. With no pressure on the cervix, dilation may or may not occur, despite regular contractions. A concern in this circumstance, particularly in women who have had a prior cesarean delivery, is that of uterine rupture or dehiscence of the uterine scar. Though this complication has not been published as having occurred in a woman with dwarfism, uterine rupture is a well-known complication of obstructed labor. 27 Thus, the decision to intervene for preterm labor may have to be made on the basis of contractions alone in women with skeletal dysplasia, particularly those with a small pelvis.
As it was addressed in statement 5 regarding fluid management, selection of a tocolytic agent, dosage, and volume of infused fluids must be adjusted from standard dosing based on the stature of the patient to avoid volume overload.
7)
Anatomical differences in women with skeletal dysplasia increase the risk of general and regional anesthesia during pregnancy and delivery, and require advanced planning when possible.
Anatomical differences in women with skeletal dysplasia that might impact general and regional anesthesia include those affecting the spine and craniofacial bones. Abnormal structure of the vertebrae is a common feature of skeletal dysplasia, typified by achondroplasia, in which there is significant stenosis of the spinal canal. Similarly, individuals with spondyloepiphyseal dysplasia congenita have irregularly shaped vertebral bodies that may be flatter than usual (platyspondyly) and are anatomically of different sizes (anisospondyly), 28 often resulting in scoliosis and kyphosis. Additionally, prolapse of intervertebral discs and thickening of the interspinal ligaments may result in further narrowing of the spinal canal. 29 As a result, regional anesthesia can be technically difficult, if not dangerous, in this population and the logistics of successful execution are more appropriately assessed in advance of delivery, rather than in the acute setting.
Similarly, general anesthesia may have associated technical difficulties because of involvement of craniofacial bones in skeletal dysplasia, as well as concerns around instability or stenosis of the craniocervical junction and subaxial cervical spine. Narrowing of the nasopharynx and relative hypertrophy of associated soft tissues can not only result in technical difficulties of intubation, but may also cause undetected medical problems resulting from longstanding obstructive sleep apnea, such as hypertension, atrial fibrillation, and increased risk of myocardial infarction and Expert Reviews ajog.org (2) 53.8% (7) 30.8% (4) 5. Ultrasound should be main imaging modality to diagnose suspected antenatal skeletal dysplasia.
33.3% (4) 50.0% (6) 8.3% (1) 0 8.3% (1) 6. Indicators of lethality are very important in scenario of antenatal suspected skeletal dysplasia.
75.0% (9) 25.0% (3) 0 0 0 7. Best indicator of lethality is micromelia. 0 0 0 91.7% (11) 8.3% (1) 8. Best ultrasound indicators of lethality are combination of above.
33.3% (4) 58.3% (7) ajog.org Expert Reviews (2) 6. 3D ultrasound should be used routinely in further assessment of suspected skeletal dysplasia.
8.3% (1) 58.3% (7) 25.0% (3) 8.3% (1) With careful preparation and in partnership with her obstetrician, a woman with a short stature skeletal dysplasia can have a safe and healthy delivery outcome. Ideally, long before presenting to a delivery ward in labor, the mother and her support partner should meet with her obstetrician to discuss which hospital(s) have personnel available 24/7 to manage specific, potential maternal and fetal complications that may occur during labor and delivery. 30 For the mother, this may include the need for general anesthesia instead of epidural, due to neurologic risks of administration of medication directly into the spine or epidural space. In women with some dysplasia diagnoses, the airway also may be quite difficult to access successfully due to cervical instability, cervical immobility (secondary to previous surgical fusion), or a short neck. 31 For these women, fiberoptic intubation by an appropriately trained health care provider must be readily available at all times at the hospital where she presents to deliver. If the mother's spinal anatomy allows for safe administration of epidural or spinal anesthesia during her cesarean delivery, and she wishes to avoid general anesthesia, it is important to discuss the comfort and willingness of the relevant obstetrician and obstetric anesthesiologists to abide by this. 30, 32, 33 Some obstetric anesthesiologists are more comfortable controlling the airway throughout delivery with general anesthesia and will not accommodate a patient's request otherwise. The earlier a mother with a skeletal dysplasia can address these questions with her physician, the more time and opportunity she will have to seek out additional opinions from caregivers who may be able and willing to accommodate her delivery plans.
For the infant, the mother should explore with her obstetrician and future pediatrician the availability of appropriate newborn care at the hospital where she plans to deliver. The scope, intensity, and urgency of pediatric services that may be needed immediately after delivery may be anticipated based on the presumed or suspected skeletal dysplasia diagnosis of the infant. If not, potential problems to consider include immediate management of respiratory distress and long-term management of the complications associated with premature delivery. In either of these situations, resuscitation including intubation and ventilation may be needed. A skilled health care provider is required on site to perform this procedure. After stabilization, additional pediatric services may include prolonged ventilator support, nasogastric tube feeding, and imaging. There are different levels of neonatal care available in hospitals, so preemptive consideration of requirements before delivery is advised.
10) Women with skeletal dysplasia char-
acterized by a short trunk should be identified as they are at higher risk during pregnancy for cardiopulmonary complications, maternal complications, and preterm delivery. 11) In pregnant women with skeletal dysplasia, vigilance is required as increasing fundal height may adversely affect maternal cardiopulmonary and musculoskeletal status.
All short stature skeletal dysplasia conditions include some degree of truncal shortening as part of their phenotype. With a shorter trunk, there is a smaller chest cavity and therefore smaller lung volumes to support general cardiopulmonary function in a woman with a short trunk skeletal dysplasia. 32 Relative to the severity of its influence on cardiopulmonary function prior to pregnancy, truncal shortening will continue to affect the woman throughout pregnancy. If general physical function is intact prior to pregnancy (ie, can ambulate around home and in the community to perform activities of daily living), then fairly normal function from a cardiopulmonary and musculoskeletal 34 However, as the gravid uterus compresses upward on the chest cavity, dyspnea with and without exertion will become more apparent. This should be monitored throughout pregnancy and particularly in the third trimester when preterm delivery (<34 weeks) may be considered if the mother exhibits medical complications (eg, hypoxia) that would prompt early cesarean delivery in any pregnant woman. It should be noted that physical function of a pregnant woman may also be heavily influenced by neurologic manifestations of her underlying skeletal dysplasia diagnosis (eg, lumbar spinal stenosis in achondroplasia). Ideally, the neurologic status (ie, reflexes, gait, motor exam, central nervous system imaging) of a woman will be assessed prior to pregnancy to be used as comparison throughout the gestation to help determine the etiology and monitor the progression of new symptoms. 12) Pelvic anatomy in most women with skeletal dysplasia precludes vaginal delivery, and cesarean delivery is recommended. 13) A woman with skeletal dysplasia can have a cesarean delivery with a Pfannenstiel skin incision and low transverse uterine incision.
In general, cesarean delivery will be necessary for a mother with a short stature dysplasia to deliver her infant due to the small and compressed shape of her pelvic outlet. Aside from the rare occurrence of an adequately sized pelvis in a mother with a mild form of hypochondroplasia, for example, the infant's cranium will be too large to pass through the birth canal whether average stature with normocephaly or short statured with macrocephaly (ie, infant with achondroplasia). 32, 35 Barring other obstetrical issues, a woman with a skeletal dysplasia can have a cesarean delivery with a Pfannenstiel skin incision and low transverse uterine incision. 32, 33, 35 Pregnancy and delivery of newborns suspected with skeletal dysplasia 14) Prenatal diagnosis of a suspected fetal skeletal dysplasia is important in terms of pregnancy management and counseling. 15) Pregnancies in which there is a suspected fetal skeletal dysplasia should be referred to appropriate centers with high-level ultrasound expertise and expert evaluation. 16) Pregnancies in which there is a suspected fetal skeletal dysplasia should be referred to appropriate high-risk maternal fetal medicine/ perinatal medicine specialists for management or recommendations for management. 17) Counseling of a couple with a suspected skeletal dysplasia should include discussion of possible therapies/new treatments.
In terms of prenatal diagnosis of short stature skeletal dysplasias, we had strong consensus and unanimous agreement that a pregnant woman carrying a fetus with a suspected dysplasia should be referred to an appropriate center where high-level ultrasound and expert evaluation of the skeleton is available, specifically a high-risk maternal fetal medicine/perinatal medicine specialist, because prenatal diagnosis of a skeletal dysplasia is important to direct pregnancy management and counseling. If the dysplasia is suspected to be nonlethal, then counseling of that couple should also include a discussion of possible therapies and new treatments that may be available to the child.
18) If possible, instrumentation during
delivery should be avoided when fetal skeletal dysplasia is suspected due to the increased risk of intracranial and cervical spine complications.
Delivery instrumentation includes forceps and vacuum, which are most commonly used to assist in vaginal delivery, though are occasionally used for cesarean deliveries. They can prevent the need for cesarean delivery or expedite delivery for maternal or fetal indications. Operative vaginal delivery accounted for 3.21% of deliveries in the United States in Forceps apply direct traction on the fetal skull, while vacuum applies traction to the fetal scalp. In their Practice Bulletin on operative vaginal delivery ACOG note that, "a live fetus known or strongly suspected to have a bone demineralization condition (eg, osteogenesis imperfecta)" is a contraindication to operative vaginal delivery. 36 The rationale is apparent, as the instrument can easily fracture the fragile skull. Both forceps and vacuum deliveries are intended to assist the baby in navigating the birth canal in a physiologic manner. However, it is possible to place added stress on the cervical spine, as the flexion and extension of the neck is imposed by the traction of the operator on the forceps or vacuum rather than the descent associated with normal progress in labor and maternal expulsive efforts. Cervical spine concerns exist in about 25% of skeletal dysplasias. 37 Importantly, many have C1e2 instability, potentially placing the spinal cord at risk. To avoid harm to babies known or suspected to have a skeletal dysplasia on the basis of prenatal ultrasound and/or diagnostic testing, operative delivery should be avoided when possible.
19) All fetuses with prenatal suspected skeletal dysplasia should be delivered in a tertiary center with appropriate pediatric care and neonatal intensive care unit facilities.
Consensus was not achieved on the type of hospital in which a neonate with a suspected skeletal dysplasia should be delivered, with 23% agreeing the infant should be delivered in a tertiary center, 38% neutral, and 38% disagreeing with this statement. With further discussion, there was agreement that delivery should occur at a tertiary care center with appropriate pediatric care and neonatal intensive care unit facilities if there was prenatal evidence of congenital anomalies (eg, cardiac malformation) in addition to the dysplasia or concern that the dysplasia could be lethal. In contrast, a fetus with only shortened long bones, normal chest size (and therefore presumed normal pulmonary development), and an uncomplicated gestation could be delivered at a local, nontertiary care medical facility. Ideally this is a determination that would be reached by the patient and her obstetrician before presentation for delivery.
20) Incidence of fractures in children with
prenatal diagnosis of osteogenesis imperfecta is not decreased by cesarean delivery.
In a recent study by Bellur et al 38 on 540 osteogenesis imperfecta cohorts, multivariate analyses showed that atbirth fracture rates did not differ based on whether delivery was by vaginal route or by cesarean delivery. Cesarean delivery involves significant forces on the fetal limbs through a relatively small incision in the uterine wall as compared to the relatively uniform pressure exerted by the muscular birth canal during vaginal delivery. Hence, the recommendation of this group is that cesarean delivery should be performed only for other maternal or fetal indications, but not for the sole purpose of fracture prevention.
Prenatal diagnosis of skeletal dysplasia 21) As the modes of inheritance vary among skeletal dysplasias, establishing the correct diagnosis and individualized preconception genetic counseling are important.
Molecular diagnosis is a key part of the diagnostic pathway that also includes radiographic evaluation. Some types of skeletal dysplasia characterized by perinatal lethality may be genetically heterogeneous and have different recurrence risks, making molecular diagnosis useful in distinguishing between different subtypes. For example, achondrogenesis, a prenatally detectable, lethal condition, may have a <1% recurrence risk when it is associated with de novo mutations in COL2A1, or 25% if associated with autosomal recessive TRIP11 or SLC26A2 homozygous mutations. This can be directly discernible through appropriate molecular testing. 39 
22)
Prenatal genomic test results need to be ordered and interpreted by a qualified expert and must be correlated with clinical findings.
Next-generation sequencing allows rapid, high-throughput genetic testing of a number of genes simultaneously. This has revolutionized diagnostic testing, including within the context of skeletal dysplasia, 40 and certainly makes a valuable contribution to clinical pregnancy Savarirayan. Prenatal evaluation and delivery of patients with skeletal dysplasia. Am J Obstet Gynecol 2018.
Expert Reviews ajog.org planning; however, it must be conducted in the expert genomic medicine arena. This is most likely to be accomplished through a clinical geneticist with skeletal dysplasia expertise working in a multidisciplinary forum. Several filtering steps are required to determine which variants have clinical significance and are of sufficient pathogenicity in genes associated with the phenotype. 41 As such, the interpretation of genomic test results must be undertaken by an expert with oversight of this pathway. Lack of knowledge of this genetic testing strategy can easily lead to misdiagnosis and inappropriate genetic counseling.
23)
Increased nuchal translucency at 10e14 weeks of gestation can be a sign of a severe skeletal dysplasia.
24)
The most likely time in pregnancy to detect features of a skeletal dysplasia is 18e20 weeks of gestation. 25) Prenatal next-generation skeletal panel gene sequencing or whole exome/genome testing should be offered to increase diagnostic yield in suspected skeletal dysplasia. 26) Most of the severe skeletal dysplasias are detected at the routine ultrasound performed at 18e20 weeks of gestation.
These statements relate to timing and type of screening studies and genetic testing available when a skeletal dysplasia is suspected in the prenatal period. 42e44 The earlier in gestation skeletal and other structural anomalies are detected, generally the worse the clinical phenotype of that affected fetus. Increased nuchal translucency at 10e14 weeks' gestation may be a predictive sign of chromosomal disorders including Down syndrome and congenital heart disease. If accompanied by distinctive skeletal features such as shortened or bowed limbs, abnormal chest or ribs, and undermineralized skull, we were in agreement that increased nuchal translucency at the end of the first trimester is a highly suggestive of a severe skeletal dysplasia. Though 18e20 weeks' gestation is the time most likely to identify a skeletal dysplasia, we emphasize that this may be simply due to the fact that this is the typical point in gestation in which pregnancies are screened for birth defects and growth.
We were unable to reach consensus on a statement pertaining to whether nextgeneration sequencing of skeletal dysplasia gene panels or comprehensive whole exome/genome testing should be offered in the prenatal period. It should be recognized that at least part of our ambiguity about this statement is related to the current state of the technology. If a dysplasia is suspected at 18e20 weeks' gestation (ie, the time of routine fetal anomaly screen) the results of a large gene panel or whole exome/genome sequencing may not be available soon enough to act upon, should the results prove to be consistent with a lethal dysplasia. With time, as the test methodology improves and results may be reached more quickly, such testing will be feasible and probably should be offered. For now, pretest counseling should be offered to all potential patients for the strengths and limitations of such testing. Increasingly, noninvasive prenatal diagnosis of skeletal dysplasia is available and has its place in the diagnosis of single gene disorders, such as achondroplasia and thanatophoric dysplasia. 45 27) Nonlethal skeletal dysplasia may not be evident by ultrasound until !28 weeks of gestation. 28) Some types of skeletal dysplasia may not be evident until birth.
As discussed above, the earlier in gestation a skeletal dysplasia is detected, the more severe the clinical phenotype of that affected fetus is likely to be. There was consensus that many nonlethal skeletal dysplasias are not evident until !28 weeks' gestation. This is certainly true for achondroplasia, the most common nonlethal skeletal dysplasia. For achondroplasia, fetal biometry and anatomy are usually normal in the second-trimester scan. 46 Continuing with this thinking, some short stature skeletal dysplasias may not be apparent at birth or even up until the second year of life. For example, though specific skeletal changes are present at birth in all infants with achondroplasia (ie, proximal femoral lucency, iliac flaring, interpedicular narrowing of lumbar vertebrae, metaphyseal flaring), such radiographs may not be obtained in the immediate perinatal period if rhizomesomelia and midface hypoplasia are mild and the newborn length falls within the normal range of average stature infants. As shown by Hoover-Fong et al 47 in a large cohort of achondroplasia patients, newborn length was on average within 1 cm of the reference infant cohort included in the 2000 Centers for Disease Control and Prevention growth charts. However, by 6 months of age, all overlap in length between the achondroplasias cohort and average stature infants had separated with all achondroplasia patients plotting significantly (e2.0 SD) below the mean. In patients with pseudoachondroplasia, there is a similar lag in newborn and infancy length separation from average stature children, sometimes as late as 2 years of age. Again, radiographs of the spine and hands would reveal easily recognizable features of pseudoachondroplasia from birth (ie, anterior vertebral beaking, generalized epiphyseal dysplasia), but are usually not obtained until concerns about linear growth arise at !1e2 years of life. Since radiographic features of most of the short stature skeletal dysplasias are present immediately at birth, we acknowledge they also may be detectable in the prenatal period. However, routine 2-dimensional (2D) ultrasound is not often sensitive enough to visualize subtle skeletal differences that would suggest the presence of a dysplasia. Computed tomography (CT) and plain film imaging-though much better for skeletal imaging-are not often employed during pregnancy due to concerns over radiation exposure in the former and inability to secure precise fetal positioning in the latter.
29)
Ultrasonography remains the main imaging modality to diagnose suspected prenatal skeletal dysplasias.
As part of standard prenatal care, screening ultrasound is often performed at 18e20 weeks to evaluate for congenital ajog.org Expert Reviews anomalies. Early features of some skeletal dysplasias can be detected at this time, such as short limb length (femur length [FL] or humerus length <5th percentile or >2 SD below the mean 48 and angulation and deformity of long bones, although precise prenatal diagnosis is often difficult. 49 Additional sonographic findings such as congenital heart disease, renal and brain anomalies, and other skeletal anomalies can also discriminate between various syndromes and skeletal dysplasias. Less uniformly available is 3-dimensional (3D) ultrasound, which can assist in the assessment of facial features that are characteristic of certain disorders. 48 30) Plain radiographs are not helpful refining the diagnosis of suspected skeletal dysplasias.
Historically, in utero radiographs of a fetus with suspected skeletal dysplasia were obtained in addition to fetal ultrasound to confirm diagnosis. Improvements in ultrasound have made this modality lower in value. 48 Additionally, maternal structures typically obscure the fetal skeleton, limiting the evaluation, and few medical centers have the expertise to diagnose by this method. Ideally, plain radiography would be avoided in the prenatal imaging assessment of skeletal dysplasias, as the developing fetus is sensitive to the effects of ionizing radiation. Safer and more effective diagnostic methods such as ultrasound, and in certain cases magnetic resonance imaging (MRI), are generally preferred prenatally. In the postnatal period, plain radiography can be extremely helpful for diagnosis, with the skeletal survey being the typical imaging modality. 31) Low-dose CT scanning can be helpful refining the diagnosis of suspected skeletal dysplasias.
Prenatal diagnosis of skeletal dysplasia with 2D ultrasound has sensitivity rates of only 40e60%. 50 Low-dose CT, while not considered a primary screening imaging modality due to its use of ionizing radiation, can potentially be a useful adjunct as it generates very clear details of osseous structures, and improves diagnostic accuracy. 50 Threedimensional reformations and multiplanar reconstructions of the skeleton can be generated for improved diagnostic accuracy. 51 As with all pediatric imaging, care should be made to reduce radiation exposure to a level that is "as low as reasonably achievable," following published American College of Radiology guidelines for imaging fetal patients. 52 32) 3D ultrasonography can be helpful refining the diagnosis of suspected prenatal skeletal dysplasias. 33) Prenatal MRI scanning can be helpful refining the diagnosis of suspected skeletal dysplasias.
Further imaging beyond standard 2D ultrasound is not typically required. Three-dimensional ultrasound can be helpful in distinguishing facial abnormalities that may help differentiate disorders with distinct craniofacial differences, thus limiting the scope of diagnoses detected by this modality. Fetal MRI is most useful for analysis of the spine where there is suggestion of scoliosis, diastematomyelia, or vertebral malformations. Determination of lethality is of obvious importance to the management of the pregnancy with suspected skeletal dysplasia. Ultrasonographic features that have been associated with lethality include long-bone shortening (micromelia), small chest with short ribs, abnormal cardiothoracic ratio, decreased bone echogenicity (ie, mineralization), and marked bowing or fractures. Chest to abdomen ratio, FL to biparietal diameter, and hydrops are also associated with lethality. 53, 55, 56 Chest circumference <5th percentile for gestational age has been proposed as an indicator of pulmonary hypoplasia. Another parameter used is a chest circumference/AC ratio <5th percentile. 57 Lung area and thoracic circumference/AC ratio have the highest diagnostic accuracy for lethal pulmonary hypoplasia. The presence of hydrops has historically been associated with lethality as well. Hydrops is associated with lethal forms of osteogenesis imperfecta: mucopolysaccharidosis type VII (Sly syndrome) and hydrops-ectopic calcification "motheaten"/Greenberg skeletal dysplasia. Accurate prediction of lethality has historically been based on the utilization of multiple indicators. Hersh et al 62 found that lethality could be accurately predicted prenatally in all cases (100%) reviewed. Their determination of lethality was based on the presence of at least 2 ultrasonographic findings, including severe FL shortening (<1st centileefound in all subjects), decreased bone echogenicity, or a small, bellshaped thorax. 62 Gaffney et al 53 found that additional ultrasonographic findings, apart from limb shortening, angulation, and/or hypomineralization, such as small chest size, hydrops, and polyhydramnios were present in 22 of 29 cases. The most common of these associated findings was the subjective finding of a small chest in 16 cases. 53 By far, the single best predictor of lethality has been FL/AC ratio. 63e65 Ramus et al 64 found that 12 of the 13 infants with a FL/AC ratio <0.16 had a lethal skeletal dysplasia. No infant with a ratio >0.16 had a lethal dysplasia. Two infants with a ratio between 0.16e0.18 had nonlethal dysplasias, while 4 of 8 infants with a ratio between 0.18e0.20 had a nonlethal dysplasia. They found that no infant with a ratio >0.20 had Expert Reviews ajog.org evidence of any skeletal dysplasia. One patient with a FL/AC ratio <0.16 and a nonlethal skeletal dysplasia presented with marked bowing, consistent with osteogenesis imperfecta. A special caveat noted in this article is that ultrasonographic images with bowing of the femur must be carefully evaluated and that a more accurate measurement of the actual length of the femur, rather than the distance between each end of the femur, be measured to obtain a useful ratio. The group of confirmed lethal skeletal dysplasias had a mean (and SD) FL/AC ratio of 0.106 AE 0.026. The nonlethal group had a mean of 0.187 AE 0.020 with a 95% confidence interval of 0.182e0.192.
In evaluating many of these same factors, (ie, sonographic measurements including micromelia, an FL/AC ratio of <0.16, hypoplastic thorax, cloverleaf skull, or multiple fractures), Parilla This article also reported that 3 of the 17 nonlethal skeletal dysplasias had an FL/AC ratio of <0.16. The diagnoses for those 3 included osteogenesis imperfecta with a fracture, achondroplasia, and Roberts syndrome. Consequently, these authors also recommended careful evaluation of bowed limbs, more specifically an accurate measurement of the actual length of the femur rather than the linear distance between each end of the femur.
More recently, Nelson et al 65 demonstrated that pregnancies complicated by lethal skeletal dysplasia had a significantly lower FL/AC ratio and were more likely to have a ratio <0.16 than those with neonatal survival (91% vs 11%). They also found that FL <5th percentile for expected gestational age was identified in more than two thirds of the pregnancies evaluated. Thoracic circumference, thoracic circumference to AC ratio, and cardiothoracic ratios were not discriminatory. Additionally, these authors found that pregnancies with hydramnios were less likely to survive to hospital discharge.
36) The finding of a FL 5th percentile for gestational age during the 18-to 22-week ultrasound warrants further evaluation.
FL is one of the commonly used and easy-to-perform biometry measurements of the second-trimester ultrasonography. Short FL is defined as <5th centile or e2 SD for gestational age. There are several conditions associated with short FL including skeletal dysplasia, aneuploidies, intrauterine growth restriction, uteroplacental insufficiency, and small-for-gestational age infants.
Papageorghiou et al 66 conducted a retrospective review of 129 cases of fetal FL <5th centile at 18e24 weeks of gestation. Skeletal dysplasia comprised 16 cases, which included 3 asphyxiating thoracic dystrophy, 2 osteogenesis imperfecta, 2 thanatophoric dwarfism, 2 campomelic dysplasia, 2 unspecified skeletal dysplasia, and 1 case each of Caffey disease, diastrophic dysplasia, fibrochondrogenesis, fibular hemimelia, and focal femoral hypoplasia.
This statement does not necessarily mean that fetal skeletal dysplasia can be excluded if the FL is within normal range at the second trimester. Skeletal dysplasia, not associated with significant fetal growth disturbance of the long bone, can show a FL within physiologic range in utero or before the third trimester. Even achondroplasia, the most common skeletal dysplasia characterized by rhizomelia, may show a short femur only in the third trimester. 67 Widening of the femoral proximal diaphysismetaphysis angle has been suggested as a marker for fetal achondroplasia when short femur was not yet apparent. 46 If a short femur is detected in fetal ultrasonography, further evaluation should include measuring the length of the other long bones, evaluating their shape and mineralization, and measuring AC and head circumference to calculate their ratio to the femur. 37) Fetal DNA obtained for genetic testing should be retained for further evaluation until a correct diagnosis is established.
In the event that a skeletal dysplasia condition appears clinically to be lifelimiting in the prenatal period, DNA collected from an affected fetus should be stored to ensure that an accurate diagnosis can be met. This is with the long-term view of establishing a molecular diagnosis for the purpose of offering appropriate genetic counseling to the parents. 48 Specifically, it is essential to determine the recurrence risk, whether it is negligible or of higher probability in the event of a transmissible mutation.
38)
Postmortem evaluation is recommended for fetuses from pregnancies terminated due to suspected skeletal dysplasia.
In respect of arriving at an accurate diagnosis to inform future genetic counseling around recurrence, prognosis, and potential management through prenatal diagnosis, full diagnostic workup is essential. Postmortem evaluation through autopsy with x-ray imaging is mainstay. This allows the full clinical picture to be determined. Key diagnostic clues can be ascertained, in other, extraskeletal systems, which can then inform appropriate genetic testing, such as high-throughput sequencing.
Examples of this include the skeletal dysplasia conditions associated with ciliopathy, such as Jeune asphyxiating thoracic dystrophy, which is allelic to lethal short-rib-polydactyly syndromes. This group of disorders characterized by extraskeletal manifestations in the kidneys, liver, retina, and lungs, are complex and genetically heterogeneous, requiring full clinical workup to interpret as accurately as possible molecular test results. 68 This will then promote effective genetic counseling and permit appropriate early prenatal diagnosis. It is recognized that some parents are not willing to consent to full postmortem examination of a fetus following termination of pregnancy. In this situation, external evaluation with clinical ajog.org Expert Reviews photographs and radiographic survey are essential, but do not replace the full examination in providing key diagnostic information. 69 Considerations for newborns with skeletal dysplasia 39) All newborns with suspected skeletal dysplasia should be evaluated as soon as practical after delivery, regardless of previous diagnosis or prognosis. 40) If fetal skeletal dysplasia is suspected but a specific diagnosis is not known at birth, referral to a specialist center for diagnostic assessment and management is recommended. 41) If a specific skeletal dysplasia diagnosis is known at birth, then appropriate management should be instituted.
Given the number of distinct skeletal dysplasias 2 and their phenotypic variability, making the exact diagnosis of a specific skeletal dysplasia in pregnancy based on ultrasonography is challenging. 48 It is therefore of paramount importance that all newborns suspected of having a skeletal dysplasia are carefully evaluated after delivery to confirm or refute its presence with the aim of making a specific diagnosis through clinical examination, skeletal radiographic surveys, and appropriate molecular testing where applicable. This includes situations in which a lethal skeletal dysplasia is suspected, so that palliative measures or appropriate medical intervention can be put in place, specific to the medical situation and parental wishes.
In the event that skeletal dysplasia is diagnosed, onward referral to a specialist center for further diagnostic assessment and management is recommended. The benefits of such a referral include: establishment of a specific diagnosis; delineation of natural history; institution of specific therapies (eg, enzyme replacement therapy for hypophosphatasia) and anticipatory screening for associated comorbidities (eg, sleep apnea, hearing loss, renal failure); accurate family genetic counseling for recurrence risks; and offering potential prenatal testing of subsequent pregnancies and preimplantation genetic diagnosis if a molecular confirmation of the clinical diagnosis is available. Early and accurate diagnosis of a newborn with a skeletal dysplasia also allows potential referral for institution of a specific natural history altering therapy and appropriate medical monitoring, which is increasingly becoming a reality in skeletal dysplasias (Yap and Savarirayan 70 in 2016).
42)
Postnatal skeletal surveys are helpful in the diagnosis of skeletal dysplasia.
Imaging techniques such as 2D and 3D fetal ultrasonography, as well as in utero radiography, fetal MRI, and fetal CT may be useful in detecting presence of skeletal dysplasia in the fetus. However, making a diagnosis of a specific skeletal dysplasia in the fetus remains difficult except for achondroplasia, thanatophoric dysplasia, or osteogenesis imperfecta, which show unique characteristics. Many of the skeletal dysplasias are very diverse and their phenotypes overlap each other. A recent series reported that the suspected prenatal diagnosis was correct in only 79.3%. 49 Therefore, we concurred that postnatal skeletal survey is helpful in the diagnosis of skeletal dysplasia as well as molecular testing, if available.
Summary
Pregnant women and unborn fetuses with skeletal dysplasia present unique concerns. Due to the relative rarity of these conditions individually, many centers have little or no experience with the pitfalls that may exist when caring for this group. This report intends to outline the best practices in prenatal evaluation and delivery of patients with skeletal dysplasia. In general, prenatal evaluation and delivery care should be performed by appropriately experienced personnel. For the pregnant mother with skeletal dysplasia, thorough preconception genetic counseling, pregnancy evaluation, and discussion of management of delivery are recommended. For the fetus with suspected skeletal dysplasia, this panel recommends diagnostic assessment through prenatal genomic tests and imaging through ultrasonography and MRI imaging, parental counseling, and appropriate postnatal management.
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